Other languages Intellia Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2026-04-15 pm EDT			5-day change	1st Jan Change
14.94 ^USD	+1.08%		+7.71%	+66.18%

Mar. 06	Nektar Therapeutics reports inducement grants under Nasdaq Listing Rule 5635(c)(4)	RE
Mar. 03	Intellia Therapeutics Presents Longer-Term Clinical Data For Lonvoguran Ziclumeran	CI

24-06-24	Los resultados del fármaco de Alnylam Pharmaceutical se consideran el "mejor escenario posible" -- Market Talk
22-10-17	Índices: Cathie en el tapete
22-10-17	Indices : Cathie au tapis
21-12-10	Novartis-CEO: Möglicher Verkauf von Sandoz stösst auf grosses Interesse
21-12-10	Novartis-Chef: Möglicher Verkauf von Sandoz stösst auf Interesse
21-08-06	El Informe Semanal del Inversor : En el séptimo cielo
21-07-23	BB Biotech : utile netto 1* sem a 349 mln chf (422 mln chf 1* sem 20)
18-07-17	Dow Jones Industrial Average : Wall Street finit dans le désordre, le pétrole pèse